On July 26, 2023, AC Immune SA announced the appointment of Nuno Mendonça, MD. Effective October 1, 2023, Dr. Mendonça will join the Company as Chief Medical Officer and be appointed to the Executive Committee. Johannes Streffer, MD, currently Chief Medical Officer, will leave at the end of September.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.5 USD | +0.81% | +5.49% | -50.00% |
Mar. 15 | AC Immune Files $350 Million Mixed Shelf | MT |
Mar. 14 | AC Immune SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.00% | 235M | |
+0.67% | 42.4B | |
+46.34% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- ACIU Stock
- News AC Immune SA
- AC Immune SA Announces Executive Changes